Pulmonary arterial hypertension (PAH), which belongs to the first group, is a rare complication in HHT and is related to mutations in components of the TGF-β pathway; 75% of these mutations are found in BMPR2. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.